export interface JournalArticle {
  slug: string;
  label: string;
  title: string;
  excerpt: string;
  image: string;
  publishedDate: string;
  readTime: string;
  body: string[];
  /** Optional end-of-article CTA (e.g. wholesale/dropshipping posts linking to /wholesale). */
  cta?: { label: string; href: string };
}

export const JOURNAL_ARTICLES: JournalArticle[] = [
  {
    slug: "understanding-peptide-purity",
    label: "Purity",
    title: "Understanding peptide purity",
    excerpt: "How purity is evaluated and why independent verification matters more than the number on the label.",
    image: "/images/science/purity.jpg",
    publishedDate: "2026-08-03",
    readTime: "6 min read",
    body: [
      "Purity, in the context of a research peptide, describes how much of a vial's mass is the target compound versus everything else that can end up in a synthesis: residual solvents, unreacted amino acids, salts, and truncated or deletion sequences that share most of the target molecule's structure but not all of it. A purity figure is a ratio, not a guarantee of identity, which is why purity and identity are tested separately and reported together.",
      "The standard method for quantifying purity is high-performance liquid chromatography, or HPLC. A sample is pushed through a column that separates its components by how they interact with the column material, and each component exits at a different time and produces its own peak on a chromatogram. The target peptide's peak area, measured against the total peak area of everything that eluted, is what produces a number like 99.2%.",
      "HPLC alone cannot confirm that the largest peak actually is the intended compound. A truncated sequence missing one amino acid can be extremely close in retention time and peak shape to the full sequence, and a purity scan will not distinguish them. That is what mass spectrometry is for: it measures the molecular weight of what eluted and confirms it matches the expected mass of the target peptide, within a tight tolerance. Purity answers 'how much.' Mass spec answers 'is it actually what it claims to be.' A certificate of analysis that only reports one of the two is telling half the story.",
      "Self-reported purity, meaning a number a seller states without an independent lab result attached, carries no real accountability. There is no mechanism forcing accuracy, and a synthesis run that came back at 92% costs the same to sell as one that came back at 99%, if nobody is checking. Third-party testing exists specifically to remove that incentive: the lab has no stake in the result, and its report is the same whether the batch passes or fails.",
      "In practice, the purity number worth evaluating is one traceable to the exact product, a specific lot, a test date, and the issuing laboratory. EVLV's public library labels exact product and batch matches when available; a report for a different compound or blend should never be treated as a substitute.",
    ],
  },
  {
    slug: "batch-testing-explained",
    label: "Testing",
    title: "Batch testing explained",
    excerpt: "How laboratory documentation helps researchers evaluate a specific lot, not just a product line.",
    image: "/images/science/testing.jpg",
    publishedDate: "2026-08-11",
    readTime: "5 min read",
    body: [
      "A product page tells you what a compound is supposed to be. A batch, or lot, is the physical run of material associated with the specific item in front of you, and it is the batch—not merely the product line—that a report must identify. Two items with the same product name can come from different lots; only exact, lot-specific documentation can support a conclusion about a given item.",
      "When a product carries a batch or lot identifier, use it with the product name and labeled quantity to search the public COA library. Only an exact matching report should be used to evaluate the laboratory results for that product.",
      "Testing itself happens in two passes, run by an independent third-party laboratory rather than in-house. HPLC quantifies purity, as covered separately. Mass spectrometry confirms molecular identity, verifying that the compound present actually matches the expected mass of the target peptide rather than a structurally similar byproduct. A lot only clears as PASS once both results are in and both meet the threshold.",
      "The certificate of analysis produced from that testing is a public document. It lists the lot code, the compound, the purity result, the test date, and the pass/fail outcome, and it is published the moment it clears, not withheld or issued only on request. That is a deliberate choice: documentation that exists but isn't searchable functions the same as documentation that doesn't exist.",
      "For a researcher, the practical takeaway is to treat the lot code as the unit that matters, not the product name. When you look up a batch, you're not confirming that 'BPC-157 is supposed to be pure.' You're confirming that the specific vial you have in hand, identified by its lot code, was independently tested and passed.",
    ],
  },
  {
    slug: "inside-the-evlv-standard",
    label: "Standards",
    title: "Inside the EVLV standard",
    excerpt: "How EVLV approaches sourcing, synthesis, testing, documentation and fulfillment, end to end.",
    image: "/images/science/standard.jpg",
    publishedDate: "2026-08-19",
    readTime: "7 min read",
    body: [
      "\"Precision without compromise\" is easy to put on a page and hard to actually run as a process. In practice it breaks down into five stages, each with its own failure points, and the standard only holds if every one of them does.",
      "It starts with sourcing. Raw materials come from vetted synthesis partners, under NDA and subject to audit, rather than from whichever supplier quotes the lowest price that week. A synthesis is only as reliable as the starting materials that go into it, and that stage is invisible in a finished vial, which is exactly why it has to be controlled upstream rather than caught later.",
      "Synthesis itself is solid-phase peptide synthesis carried out in ISO-controlled facilities, with sequence verification built into the process rather than bolted on at the end. This is where a peptide's actual amino acid sequence gets built, one residue at a time, and where truncation and deletion sequences are most likely to be introduced if the process isn't controlled tightly.",
      "When third-party reports are available, review the named laboratory, reported methods, sample identity, and results rather than relying on a storefront badge. Independent documentation is useful only when it can be matched to the product under review.",
      "Once a lot clears, its certificate of analysis is published, publicly, searchable by lot code, the moment it's available. Not mailed on request, not held back for select customers. A COA that exists but can't be found by anyone who wants to check it isn't really transparency, it's paperwork.",
      "The last stage is fulfillment, and it's the one researchers notice least until it goes wrong: EVLV's compounds are lyophilized and shelf-stable in transit, which means no cold-chain packaging is required and orders dispatch next-day rather than waiting on refrigerated logistics. It's a smaller detail than synthesis or testing, but a compound that degrades in transit before it reaches a lab makes every upstream standard moot.",
      "None of these stages is meaningful in isolation. The useful standard is transparent, product-specific documentation that lets a qualified researcher verify what is actually supported and identify where information is still pending.",
    ],
  },
  {
    slug: "evlv-3-us-research-guide-2026",
    label: "Compounds",
    title: "EVLV-3 in the US: What Researchers Need to Know in 2026",
    excerpt:
      "A research overview of EVLV-3, the triple-agonist peptide under investigation at the GLP-1, GIP, and glucagon receptors, sourcing, purity standards, and US regulatory framing for in vitro research.",
    image: "/images/science/standard.jpg",
    publishedDate: "2026-08-27",
    readTime: "8 min read",
    body: [
      "EVLV-3 is studied as a triple receptor agonist, engaging the GLP-1, GIP, and glucagon receptors in a single molecule rather than the single- or dual-receptor approach of earlier compounds in the same research area. That broader receptor engagement is what makes it a compound of active interest in metabolic research, and also why it demands more from a synthesis and testing process: three-receptor selectivity depends on a sequence being exactly right, with no shortcuts in verification.",
      "As with any compound at the frontier of a research category, published data is still developing and protocols are not standardized the way they are for older, more established peptides. That makes independent verification of what's actually in a given vial more important, not less, a research program built on an unverified compound produces unverifiable results.",
      "Sourcing considerations follow directly from that. A newer compound generally means fewer manufacturing partners have real experience with it, and supply-chain maturity varies more than it does for a compound that's been in production for years. The practical response is the same one that applies to any compound: confirm purity by HPLC and identity by mass spectrometry, on the specific lot, from a third-party lab with no stake in the result.",
      "On the regulatory side, EVLV-3 is supplied in the US strictly for laboratory research, not for human or veterinary use, and not evaluated by the FDA for any indication. EVLV is a chemical supplier, not a compounding pharmacy or outsourcing facility as defined under 503A or 503B of the Federal Food, Drug, and Cosmetic Act. Research use only means exactly that: appropriate for qualified researchers working in a laboratory setting, not a substitute for medical guidance.",
      "Before sourcing any batch, the same checklist applies regardless of how new the compound is: a certificate of analysis searchable by lot code, a purity result from HPLC, and an identity result from mass spectrometry, not a spec sheet for the product line, but data for the vial in front of you.",
    ],
  },
  {
    slug: "bpc-157-us-research-guide-2026",
    label: "Compounds",
    title: "BPC-157 in the US: Complete Research Guide 2026",
    excerpt:
      "Background, characterization, and US sourcing considerations for BPC-157, a synthetic pentadecapeptide studied in preclinical research for angiogenic and growth factor signaling pathways.",
    image: "/images/science/purity.jpg",
    publishedDate: "2026-08-29",
    readTime: "7 min read",
    body: [
      "BPC-157 is a synthetic pentadecapeptide, a 15-amino-acid sequence, derived from research into a protective protein identified in gastric juice. It's one of the more extensively studied compounds in its research category, with a body of preclinical literature examining its role in angiogenesis and growth-factor signaling pathways relevant to tissue repair research.",
      "That research history is also why BPC-157 is a useful case study in what 'well studied' does and doesn't mean for sourcing. A large literature base tells you the compound itself is a legitimate subject of ongoing research. It tells you nothing about whether a specific vial from a specific supplier actually contains what the label says, at the purity the label claims.",
      "For US-based researchers, sourcing BPC-157 responsibly means the same fundamentals that apply to any research peptide: independent HPLC testing for purity, mass spectrometry for identity confirmation, and a certificate of analysis tied to the actual lot, not a generic product page. A compound's research pedigree doesn't substitute for batch-level verification.",
      "It's worth being precise about scope here: this is a research compound, supplied for laboratory and identification purposes only, not for human or veterinary use and not evaluated by the FDA for any condition. The published research on BPC-157 is preclinical, it describes what's been observed in laboratory research settings, not a validated human application.",
      "Practically, that means the diligence question for a researcher isn't whether BPC-157 has been studied. It clearly has. The real question is whether you can verify this specific batch. Look for a searchable lot code, a real HPLC/mass-spec report behind it, and a supplier willing to publish that data rather than provide it only on request.",
    ],
  },
  {
    slug: "evlv-1-vs-evlv-2-receptor-selectivity-research",
    label: "Compounds",
    title: "EVLV-1 vs EVLV-2: Receptor Selectivity in Metabolic Research",
    excerpt:
      "A side-by-side overview of single- and dual-receptor incretin research compounds: structural differences, receptor selectivity, and how each is characterized in preclinical studies.",
    image: "/images/science/testing.jpg",
    publishedDate: "2026-09-01",
    readTime: "6 min read",
    body: [
      "EVLV-1 is studied as a single-receptor GLP-1 agonist, its structure is built to engage one receptor target. EVLV-2 is a dual-receptor compound, engaging both the GLP-1 and GIP receptors within one molecule. That single structural difference is the starting point for nearly every other distinction researchers draw between the two compounds in the literature.",
      "Structurally, both are modified peptide backbones designed for extended receptor engagement relative to native incretin signaling, but they diverge in the specific modifications used to achieve that stability and in the additional GIP-binding domain present in EVLV-2's sequence. Characterizing either compound by HPLC and mass spectrometry confirms the same two things regardless of which one you're testing: how much of the sample is the target peptide, and whether its measured mass matches the expected sequence.",
      "In preclinical research, this receptor-selectivity difference is the variable most protocols are actually designed around. A single-receptor versus dual-receptor comparison is a common framing precisely because it isolates one structural variable at a time. Neither compound's research profile is inherently 'better'; they're different tools answering different questions about receptor engagement.",
      "Both compounds are supplied for laboratory research only, not for human or veterinary use, and neither is evaluated by the FDA for any indication in that context. Whatever the study design, the sourcing standard doesn't change with the compound: independent purity and identity testing, on the specific lot, published where it can actually be checked.",
      "For a researcher deciding between the two for a given protocol, the meaningful comparison is scientific, which receptor pathway the study is actually investigating, not which compound is more novel. Both have a real, growing research literature behind them.",
    ],
  },
  {
    slug: "are-research-peptides-legal-in-the-us-2026",
    label: "Regulatory",
    title: "Are Research Peptides Legal in the US? The 2026 Answer",
    excerpt:
      "A plain-language summary of the US regulatory framework around research-use-only peptides, including FDA's stance on in vitro research and the 503A/503B distinction.",
    image: "/images/science/standard.jpg",
    publishedDate: "2026-09-03",
    readTime: "6 min read",
    body: [
      "Research peptides sold for laboratory and research use are legal to purchase and possess in the US when supplied and used strictly as research use only (RUO) chemicals, not intended for human or veterinary consumption, injection, or ingestion, and not evaluated by the FDA for any medical indication. That framing is the entire basis on which a research-chemical supplier can legally operate.",
      "The key regulatory distinction is between a research chemical supplier and a compounding pharmacy. Facilities compounding drugs for human administration operate under 503A or 503B of the Federal Food, Drug, and Cosmetic Act, with a distinct set of licensing, sterility, and dispensing requirements tied to human use. A supplier of RUO research compounds is explicitly not operating under that framework, EVLV is a chemical supplier, not a compounding pharmacy or outsourcing facility as defined under 503A or 503B.",
      "That distinction is what makes the RUO label load-bearing rather than a formality. It's the legal basis for the entire product category: compounds sold for laboratory research, identification, and in vitro study, with no claim of safety or efficacy for any human or animal application, and no dosing information provided for that purpose.",
      "State-level rules can add additional wrinkles on top of the federal framework, and they vary, some states have moved on specific compounds independently of federal action. This is a summary of the general federal framework, not legal advice, and a researcher or institution with a specific compliance question should consult counsel familiar with their state's rules.",
      "The practical upshot for 2026: yes, research peptides are legal to source in the US as RUO laboratory chemicals, provided both the supplier and the buyer treat that designation as real, proper documentation, no human-use marketing, and no dosing claims, rather than as a label of convenience.",
    ],
  },
  {
    slug: "research-peptides-us-sourcing-guide-2026",
    label: "Sourcing",
    title: "Research Peptides in the US: 2026 Sourcing Guide",
    excerpt:
      "How qualified researchers evaluate US research-peptide suppliers, purity certificates, third-party HPLC testing, batch documentation, and what to verify before purchase.",
    image: "/images/science/purity.jpg",
    publishedDate: "2026-09-05",
    readTime: "6 min read",
    body: [
      "Evaluating a research peptide supplier comes down to a short list of things that are either verifiable or they aren't. Purity and identity data either exists for the specific lot you're buying, from an independent lab, or it doesn't. Everything else is secondary to that one distinction.",
      "Start with the certificate of analysis. A real COA is tied to a specific lot code, dated, and includes both an HPLC purity result and a mass-spectrometry identity result. If a supplier's 'COA' is a generic spec sheet with no lot number, or purity figures with no lab attribution behind them, that's a self-reported number, not independent verification. Self-reported purity has no accountability mechanism behind it.",
      "Next, check whether the documentation is actually accessible before you buy, not promised after. A supplier that publishes batch results searchable by lot code is making a claim that's checkable in real time. A supplier that will 'send the COA on request after purchase' is asking for trust it hasn't yet earned.",
      "Storage and fulfillment matter more than they're usually given credit for. Lyophilized compounds are shelf-stable in transit, which is one less variable to worry about; anything requiring cold-chain shipping introduces a failure point between the lab that tested it and the researcher who receives it. Ask how a supplier handles that gap.",
      "Finally, the RUO framing itself is a signal. A supplier that avoids dosing language, human-use claims, and therapeutic promises for its compounds is one that understands, and is operating inside, the actual regulatory category its products belong to. That's not a marketing detail; it's the difference between a research-chemical supplier and a liability.",
    ],
  },
  {
    slug: "peptide-shipping-warm-conditions",
    label: "Lab Guides",
    title: "What a Warm Package Actually Means for a Lyophilized Peptide",
    excerpt:
      "A vial arriving warm is not, by itself, evidence of damage. What matters is the compound, the formulation, how long it was warm, and how warm it got, not the temperature of the box.",
    image: "/images/science/standard.jpg",
    publishedDate: "2026-09-15",
    readTime: "5 min read",
    body: [
      "Freeze-drying removes water from a peptide, and water is what drives most of the degradation pathways that matter at room temperature: hydrolysis, aggregation, and oxidation all move faster in solution than they do in a dry, stable powder. That is the entire reason lyophilized compounds can tolerate a shipping cycle that a reconstituted solution never could. A package running warm for part of a transit window is not automatically the same event as a vial sitting warm and dissolved on a lab bench.",
      "Long-term storage guidance, typically a refrigerated range for a lyophilized compound, is written conservatively to preserve a product over months. It is not a minute-by-minute threshold, and treating it as one confuses two different questions: how should a compound be stored for months, and what happens to it during a two- or three-day shipping window. Those are not the same test, and conflating them leads to false alarms over ordinary transit conditions.",
      "Whether a specific warm excursion matters depends on more than the number on a thermometer: the peptide's own sequence and stability profile, its salt and formulation, how much residual moisture is in the cake, the peak temperature actually reached, how long it stayed there, and whether the vial's seal held. A supplier's own stability data on that specific compound, not a generic rule of thumb, is what answers whether a given excursion is meaningful.",
      "It is also worth separating the package's surface temperature from the vial's internal temperature. A box that feels warm to the touch has usually been sitting in a hot vehicle or a mailbox; the glass vial inside, insulated by packaging and its own thermal mass, lags well behind the air around it. Reported ambient conditions during transit are a rough proxy at best, not a direct measurement of what the compound itself experienced.",
      "None of this is a claim that shipping conditions never matter. Freezing, physical damage to the vial, prolonged direct sunlight, and genuinely extreme heat over an extended period are real risk factors worth flagging. The distinction that matters is between an ordinary transit excursion, which dry lyophilized compounds generally tolerate, and an extreme or prolonged one, which is a legitimate reason to check a lot's documentation before use rather than assume it either way.",
    ],
  },
  {
    slug: "whats-inside-a-lyophilized-peptide-vial",
    label: "Lab Guides",
    title: "What's Actually Inside a Lyophilized Peptide Vial",
    excerpt:
      "The freeze-dried cake in a vial is rarely just the target peptide. Counterions, bulking agents, residual moisture, and synthesis byproducts all take up part of that mass, and appearance alone cannot separate them.",
    image: "/images/science/purity.jpg",
    publishedDate: "2026-09-17",
    readTime: "5 min read",
    body: [
      "A lyophilized vial's visible cake is not a pure block of target compound. It is a mixture, and the target peptide is only one component of it, alongside material that was always going to be part of a real-world synthesis and formulation process. Understanding what else is in there is what makes a certificate of analysis meaningful instead of decorative.",
      "Most research peptides exist as a salt, commonly an acetate or TFA salt, because the free peptide base is rarely what comes out of a synthesis and purification run. That counterion has real mass and travels with the peptide through freeze-drying, which means a portion of the cake's weight is the salt, not the peptide sequence itself. A vial's net peptide content, the actual mass of target compound, is a distinct figure from the vial's total powder mass, and the two are not the same measurement.",
      "Many formulations also include bulking agents, excipients such as mannitol, glycine, sucrose, or trehalose, added specifically to give the freeze-dried cake structure and to protect the peptide during the drying process itself. These are standard, well-characterized additions in lyophilization generally, not a sign of dilution, but they do mean a larger-looking cake is not automatically a larger peptide dose.",
      "Residual moisture is another variable that appearance cannot reveal. Secondary drying during lyophilization leaves a small, controlled amount of water behind, and that figure is only measurable through lab methods like Karl Fischer titration, not by looking at the vial. Synthesis byproducts, truncated or deletion sequences that share most of the target's structure, and any carryover solvents from manufacturing round out the rest of what a real vial can contain, and each requires its own analytical method to detect.",
      "The practical implication is that visual inspection of a cake, its size, color, or density, tells you almost nothing about quantity, purity, or identity. Those three questions are answered separately: net content and purity by HPLC, identity by mass spectrometry, and residual solvents or moisture by their own dedicated tests. A lot-specific certificate of analysis that reports all of it is the only way to actually know what is in a given vial.",
    ],
  },
  {
    slug: "identifying-lyophilized-peptides",
    label: "Lab Guides",
    title: "Reading a Lyophilized Peptide Cake: What Appearance Does and Doesn't Tell You",
    excerpt:
      "A freeze-dried cake can look like a solid puck, loose powder, or scattered fragments in the same vial from the same lot. Physical appearance varies for reasons that have nothing to do with quality.",
    image: "/images/science/testing.jpg",
    publishedDate: "2026-09-19",
    readTime: "4 min read",
    body: [
      "It is common for a lyophilized vial to arrive looking different from how it looked the day it left production. Vibration and handling during transit are enough to shift a freeze-dried cake, which is an inherently brittle material, from a single cohesive puck into fragments or a finer, more granular texture. That change in appearance is a mechanical effect of shipping, not a change in the compound itself.",
      "Color and texture both fall within a normal range that has nothing to do with purity. A cake can be bright white, pale yellow, compact, or slightly powdery depending on the specific peptide, its formulation, and the exact parameters of that lyophilization run, and none of those variations by themselves indicate a problem with the batch.",
      "The physical form a compound takes inside the vial, a single intact cake, a cluster of fragments, or loose powder settled at the bottom, is similarly not a quality signal on its own. Two vials from the identical lot can look noticeably different from each other after the same shipping route, purely as a function of how each vial happened to be jostled in transit.",
      "What does warrant a real look is physical damage to the vial itself: a cracked or broken container, a compromised seal, or a missing or unreadable label. Those are packaging and handling issues, and they are worth flagging. Cosmetic variation in the cake is not the same category of problem, and it is not something appearance alone can diagnose one way or the other.",
      "The reliable way to evaluate a vial is the same regardless of how the cake looks: the lot code on the label and the certificate of analysis tied to it. Analytical testing, not a visual check, is what actually confirms identity, purity, and net content, and that documentation does not change based on whether a shipment arrived as one solid piece or several.",
    ],
  },
  {
    slug: "mg-versus-powder-amount",
    label: "Lab Guides",
    title: "Milligrams vs. Powder Volume: Why a Fuller-Looking Vial Isn't More Peptide",
    excerpt:
      "The milligram figure on a label describes mass, not the height of powder visible in the vial. Two vials with identical labeled content can look nothing alike, for reasons that have nothing to do with dosing accuracy.",
    image: "/images/science/standard.jpg",
    publishedDate: "2026-09-21",
    readTime: "4 min read",
    body: [
      "A milligram figure on a vial label is a statement about mass: how much of the target compound, by weight, that lot is formulated to contain. It says nothing about how much physical space that mass occupies inside the vial, and conflating the two is one of the more common misreadings of a lyophilized product.",
      "Freeze-dried powders vary enormously in density depending on the specific peptide, its salt form, the excipients used, and the exact lyophilization cycle that produced them. Some compounds form a dense, compact cake; others form a light, airy structure that fills more visible volume for the same actual mass, similar to comparing a handful of sand to a handful of feathers of equal weight. Neither density is a defect. It is simply a property of that specific formulation.",
      "This is why a 10mg vial does not reliably look twice as full as a 5mg vial from the same product line, and why two different compounds at the identical labeled dose can look nothing alike sitting side by side. Vial size is also standardized across a product range for manufacturing and packaging reasons, which further decouples what the eye sees from what the label states.",
      "None of this makes visual comparison a useful diagnostic tool, and it is not one researchers should rely on. The figure that matters, net peptide content by mass, is established through analytical testing at the point of manufacture and verified independently, not estimated by comparing cake height between vials.",
      "The reliable check remains the same one that applies across every question about a vial's actual content: a certificate of analysis, tied to the specific lot code on the label, with a net content and purity result from an independent lab. That documentation is the measurement that counts. What the cake looks like is not.",
    ],
  },
  {
    slug: "why-endotoxin-testing-matters",
    label: "Testing",
    title: "Endotoxin Testing: A Separate Test From Purity, and Why It Exists",
    excerpt:
      "Purity and identity testing confirm what a compound is. Endotoxin testing answers a different question entirely, whether bacterial contamination is present, and it uses its own dedicated method.",
    image: "/images/science/purity.jpg",
    publishedDate: "2026-09-23",
    readTime: "5 min read",
    body: [
      "Endotoxins are a component of the outer membrane of gram-negative bacteria, released when those bacterial cells die or divide. They are not the bacteria themselves, and a batch can carry a meaningful endotoxin load even when no viable organism is present, which is exactly why sterility testing and endotoxin testing are two separate procedures answering two separate questions rather than one test standing in for the other.",
      "A synthesis and manufacturing process can introduce endotoxins at multiple points: raw materials, water used in processing, or equipment and surfaces that were not adequately controlled. Because peptide synthesis is a multi-step process, contamination introduced early can persist through later steps if it is not specifically tested for at the end.",
      "The standard method for detecting and quantifying endotoxin is the LAL test, short for Limulus Amebocyte Lysate, which reacts with bacterial endotoxin in a way that produces a measurable result, typically expressed in endotoxin units per milligram or per vial. Kinetic and chromogenic variants of the LAL method allow labs to quantify endotoxin levels precisely rather than simply flagging pass or fail.",
      "Endotoxin testing sits alongside HPLC purity analysis and mass-spectrometry identity confirmation as a distinct category on a real certificate of analysis, not a substitute for either. A compound can be high purity and correctly identified by mass and still carry an endotoxin result worth knowing, which is why a complete lot-level COA reports it as its own line item rather than folding it into a general purity claim.",
      "For a researcher, the practical takeaway is the same one that applies to every other test discussed here: ask whether endotoxin testing was actually performed on the specific lot in hand, by an independent lab, with a reported result, rather than assuming a purity figure alone covers it. It doesn't. They are different measurements of different things.",
    ],
  },
  {
    slug: "why-wholesale-partners-choose-batch-verified-supply",
    label: "Wholesale",
    title: "Why Wholesale Partners Choose Batch-Verified Peptide Supply",
    excerpt:
      "What separates a durable wholesale peptide partnership from a race-to-the-bottom supplier relationship, testing, batch documentation, and why it protects your brand, not just ours.",
    image: "/images/science/standard.jpg",
    publishedDate: "2026-09-10",
    readTime: "6 min read",
    body: [
      "Building a peptide brand on top of someone else's supply chain means your reputation is only as solid as your supplier's testing practices, whether or not that's obvious on day one. A single unverified batch reaching a customer under your label is a problem your brand absorbs, not the supplier's. That is exactly why the wholesale partners who last are the ones who chose testing rigor over the cheapest quote.",
      "The mechanics of what makes a batch trustworthy don't change based on order volume. Every lot still needs independent HPLC testing for purity and mass spectrometry for identity, tied to a specific batch code, before it's fit to sell under anyone's name, yours or ours. Wholesale doesn't lower that bar; if anything, it raises the stakes, because a single lot at wholesale volume reaches far more end customers than a single retail order.",
      "This is also where documentation stops being a nice-to-have and becomes operational infrastructure. A wholesale partner needs to be able to answer a customer's question about a specific batch quickly and accurately, which means the certificate of analysis has to actually exist, be searchable, and match what shipped, not get reconstructed after the fact when a question comes in.",
      "None of this is about price positioning. It's about what a partnership needs to be durable. A supplier relationship built on verified batches, real documentation, and consistent testing is one a growing brand can build years of trust on top of. One built on unverified supply is a liability waiting for the first customer who asks a question the seller can't answer.",
      "If you're evaluating what a wholesale or white-label peptide supply relationship should look like, testing standards, batch traceability, and how fulfillment actually works day to day, that's exactly the conversation our wholesale program exists to have.",
    ],
    cta: { label: "Explore the Wholesale Program", href: "/wholesale" },
  },
  {
    slug: "white-label-peptide-dropshipping-done-right",
    label: "Dropshipping",
    title: "The Case for White-Label Peptide Dropshipping, Done Right",
    excerpt:
      "Dropshipping research peptides can mean shipping whatever's cheapest, or it can mean building a real brand on a supply chain that's actually verified. The difference is entirely in who you partner with.",
    image: "/images/science/purity.jpg",
    publishedDate: "2026-09-12",
    readTime: "6 min read",
    body: [
      "Dropshipping gets a mixed reputation in the research-chemical space, and it's earned. A lot of it is built on unverified supply, vague sourcing, and sellers who never see or test the product they're listing. None of that is inherent to the dropship model itself; it's a function of who's on the other end of the supply chain.",
      "Done properly, white-label dropshipping separates two things that don't actually need to live in the same company: building a brand, storefront, and customer relationship, and operating a compliant, testing-first supply and fulfillment chain. A founder who's good at the first doesn't need to also become an expert in HPLC testing and cold-chain-free lyophilized logistics to run a credible research-compound brand.",
      "What makes that separation workable is accurate product identification, transparent fulfillment records, and laboratory reports that are connected only to the product and batch they actually cover. The same documentation standard should apply whether an order originates through EVLV or a partner channel.",
      "The CRM/CMS and storefront side matters too, and it's often the part new brands underestimate. Order tracking, customer accounts, and batch/COA lookup tied to what actually shipped are infrastructure a dropship partner shouldn't have to build from scratch, and shouldn't want to, when it can run on a system already built for exactly this.",
      "The honest pitch here isn't that dropshipping is easy. It's that it's only worth doing on a supply chain you'd be comfortable putting your own name behind. If that's the kind of partnership you're evaluating, our wholesale and white-label program is built around exactly that standard.",
    ],
    cta: { label: "Explore the Wholesale Program", href: "/wholesale" },
  },
];

export function getJournalArticles() {
  return JOURNAL_ARTICLES;
}

export function getJournalArticleBySlug(slug: string) {
  return JOURNAL_ARTICLES.find((a) => a.slug === slug);
}
